Market Cap for Moderna (MRNA)
According to Moderna's latest reported financial statements, the company's latest reported market cap is $11.56B USD. Market capitalization is the total dollar value of all outstanding shares — shares outstanding × stock price — and the standard measure of a company's equity value. On this page, historical market cap snaps filing-period share counts to closing prices on or before each statement date (not intraday tick data).
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
MRNA
Currently viewingMarket CapSwitch metric
Latest period
$11.56B
YoY change
+55.0%
5Y CAGR
-30.5%
Peak year (2021)
$109.47B
Latest annual
$17.79B
Market Cap history chart for Moderna (MRNA) from 2018 to 2026
Market Cap history table for Moderna (MRNA) from 2018 to 2026
| Fiscal year | Period ended | Reported | Market Cap | YoY |
|---|---|---|---|---|
| 2026 | $17.79B | +55.0% | ||
| 2025 | $11.47B | -28.2% | ||
| 2024 | $15.97B | -58.0% | ||
| 2023 | $37.99B | -49.2% | ||
| 2022 | $74.72B | -31.7% | ||
| 2021 | $109.47B | +174.8% | ||
| 2020 | $39.84B | +515.7% | ||
| 2019 | $6.47B | +28.9% | ||
| 2018 | $5.02B | — |
Market Cap values are taken from Moderna's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
In 2026, Moderna (MRNA) market cap totalled $17.79B – surged 55.0% year-over-year.
Moderna market cap has contracted on net over the period, with a -30.5% compound annual growth rate over 2021–2026 (5 years).
Moderna market cap plunged from $109.47B in 2021 to $17.79B in 2026, a 83.8% drawdown.
Across the available history, market cap reached its high of $109.47B in 2021 and its low of $5.02B in 2018.
Within Healthcare, Moderna (MRNA) ranks 9th among 8 peers we track. The peer median for market cap is $311.16B.
Moderna Market Cap by Year
Moderna Market Cap 2026: $17.79B
Moderna market cap in 2026 was $17.79B, surged 55.0% from 2025.
Moderna Market Cap 2025: $11.47B
Moderna market cap in 2025 was $11.47B, declined 28.2% below 2024.
Moderna Market Cap 2024: $15.97B
Moderna market cap in 2024 was $15.97B, plunged 58.0% below 2023.
Moderna Market Cap 2023: $37.99B
Moderna market cap in 2023 was $37.99B, plunged 49.2% below 2022.
Moderna Market Cap 2022: $74.72B
Moderna market cap in 2022 was $74.72B.
See more financial history for Moderna (MRNA).
Sector peers — Market Cap
Companies in the same sector as Moderna, ranked by their latest market cap.
| Company | Market Cap | Sector |
|---|---|---|
| Eli Lilly and Company (LLY) | $825.77B | Healthcare |
| Johnson & Johnson (JNJ) | $548.34B | Healthcare |
| AbbVie Inc. (ABBV) | $349.67B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $332.91B | Healthcare |
| AstraZeneca PLC (AZN) | $289.41B | Healthcare |
| Merck & Co., Inc. (MRK) | $272.11B | Healthcare |
| Amgen Inc. (AMGN) | $183.05B | Healthcare |
| Novo Nordisk A/S (NVO) | $182.96B | Healthcare |
Frequently asked questions
What is Moderna's market cap?
- Latest reported market cap for Moderna (MRNA) is $11.56B (period ending December 31, 2025).
How has Moderna market cap changed year-over-year?
- Moderna (MRNA) market cap changed +55.0% year-over-year on the latest annual filing.
What is the long-term growth rate of Moderna market cap?
- Moderna (MRNA) market cap compound annual growth rate is -30.5% over the most recent 5 years available.
When did Moderna market cap hit its highest annual value?
- Moderna market cap reached its highest annual value of $109.47B in 2021.
What was Moderna market cap in 2025?
- Moderna (MRNA) market cap in 2025 was $11.47B.
What was Moderna market cap in 2026?
- Moderna (MRNA) market cap in 2026 was $17.79B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
MRNA Overview
Company profile, financial tools, and key metrics
MRNA Revenue Counter
Earns $61.61 every second. See per minute, hour, and day.
MRNA Earnings Counter
Loses −$89.49 per second. See per minute, hour, and day.
MRNA Economic Scale
Exceeds Timor-Leste's GDP. Compare with world economies.
MRNA What If Invested
What if you had invested $1,000? See historical returns from any date.
MRNA How It Makes Money
Discover visual breakdown of $1.94B in revenue — where it comes from and where it goes.
MRNA Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
MRNA Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
MRNA Daily Price Character
Explosive · 48.2% historical win rate (green days). Streaks & record days.
MRNA Buybacks
Recent repurchase activity. Shareholder yield & SBC comparison.